Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery.
Rice-Townsend SE, Nicassio L, Glazer D, Avansino J, Durham MM, Calkins CM, Rentea RM, Ralls MW, Wood RJ, Rollins MD, Garvey EM, Lewis KE, Reeder R, Smith CA. Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery. J Pediatr Surg. 2022 Jun; 57(6):1033-1039.